News

The endless barrage of Berserkitems is only growing stronger, with the brutal epic fantasy manga itself increasing in popularity. Now, a previous collectible release based on the protagonist is ...
confirmed that Miura’s friends are all on board in giving Berserk the finale it deserves, though the creative team hasn’t confirmed when we can expect the final chapter to arrive. In Guts ...
Her former trainer Jay Cardiello revealed to The Post how he helped J.Lo achieve those famous sculpted abs — and shared some tips on how anyone over 50 can build a strong core. “J.Lo is living ...
Berserk is a dark fantasy series that follows Guts, a former mercenary on a quest for revenge. If you're willing to take the dive, you'll find a haunting and tragic story for mature audiences ...
He was genius, had guts to cast villains in positive roles: Prem Chopra on Manoj Kumar The 87-year-old actor, who passed away on Friday due to age-related issues, had worked with Chopra in 1964's ...
Voice of America staff were locked out of their offices on Saturday—unable to complete planned reporting—after President Donald Trump signed an executive order gutting the government-run news ...
The Trump administration gutted the Institute of Peace of "rogue bureaucrats" who held a tense standoff with a Department of Government Efficiency (DOGE) team Monday that required police ...
Languages: English. You can reach Shane by emailing s.croucher@newsweek.com "Took 'guts' and courage!" Trump wrote on his Truth Social platform Friday morning, celebrating the probable aversion of ...
Fujifilm now has its own answer to the Leica Q3. Fujifilm now has its own answer to the Leica Q3. Chris Welch is a senior reviewer who has worked at The Verge since its founding in 2011. His ...
The U.S. Department of Education slashes its workforce in half, prompting deep concerns among California educators. New Education Secretary Linda McMahon said that she’s keeping the “good ...
Sutro Biopharma, a South San Francisco company working to design anti-cancer drugs, is a fresh face for biotech’s extreme risk — and its fallout. As of this year, the company had racked up ...